Follow
Gareth Jones
Gareth Jones
Verified email at petermac.org
Title
Cited by
Cited by
Year
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ...
Neurobiology of aging 31 (8), 1275-1283, 2010
11142010
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ...
Annals of neurology 69 (1), 181-192, 2011
9982011
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
CC Rowe, U Ackerman, W Browne, R Mulligan, KL Pike, G O'Keefe, ...
The Lancet Neurology 7 (2), 129-135, 2008
7762008
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ...
Annals of neurology 67 (3), 317-324, 2010
4522010
Amyloid imaging with 18F-florbetaben in Alzheimer disease and other dementias
VL Villemagne, K Ong, RS Mulligan, G Holl, S Pejoska, G Jones, ...
Journal of Nuclear Medicine 52 (8), 1210-1217, 2011
4002011
Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease
VL Villemagne, KE Pike, D Darby, P Maruff, G Savage, S Ng, ...
Neuropsychologia 46 (6), 1688-1697, 2008
3082008
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ...
Brain 135 (7), 2126-2139, 2012
2912012
Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease
S Ng, VL Villemagne, S Berlangieri, ST Lee, M Cherk, SJ Gong, ...
Journal of nuclear medicine 48 (4), 547-552, 2007
2802007
The 18F-FDG PET cingulate island sign and comparison to 123I-β-CIT SPECT for diagnosis of dementia with Lewy bodies
SM Lim, A Katsifis, VL Villemagne, R Best, G Jones, M Saling, J Bradshaw, ...
Journal of Nuclear Medicine 50 (10), 1638-1645, 2009
2772009
Predicting Alzheimer disease with β‐amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing
CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ...
Annals of neurology 74 (6), 905-913, 2013
2462013
Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease
VL Villemagne, RS Mulligan, S Pejoska, K Ong, G Jones, G O’Keefe, ...
European journal of nuclear medicine and molecular imaging 39, 983-989, 2012
2072012
Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition
G Chételat, VL Villemagne, N Villain, G Jones, KA Ellis, D Ames, ...
Neurology 78 (7), 477-484, 2012
2022012
High striatal amyloid β-peptide deposition across different autosomal Alzheimer disease mutation types
VL Villemagne, S Ataka, T Mizuno, WS Brooks, Y Wada, M Kondo, ...
Archives of neurology 66 (12), 1537-1544, 2009
2022009
Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia
CC Rowe, S Pejoska, RS Mulligan, G Jones, JG Chan, S Svensson, ...
Journal of Nuclear Medicine 54 (6), 880-886, 2013
1912013
Epilepsyecosystem. org: crowd-sourcing reproducible seizure prediction with long-term human intracranial EEG
L Kuhlmann, P Karoly, DR Freestone, BH Brinkmann, A Temko, ...
Brain 141 (9), 2619-2630, 2018
1842018
Larger temporal volume in elderly with high versus low beta-amyloid deposition
G Chetelat, VL Villemagne, KE Pike, JC Baron, P Bourgeat, G Jones, ...
Brain 133 (11), 3349-3358, 2010
1672010
In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with 18F-AV-133
N Okamura, VL Villemagne, J Drago, S Pejoska, RK Dhamija, ...
Journal of Nuclear Medicine 51 (2), 223-228, 2010
1522010
A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
SC Burnham, NG Faux, W Wilson, SM Laws, D Ames, J Bedo, AI Bush, ...
Molecular psychiatry 19 (4), 519-526, 2014
1252014
Independent contribution of temporal β-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer’s disease
G Chetelat, VL Villemagne, KE Pike, KA Ellis, P Bourgeat, G Jones, ...
Brain 134 (3), 798-807, 2011
1212011
Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults
YY Lim, KA Ellis, RH Pietrzak, D Ames, D Darby, K Harrington, RN Martins, ...
Neurology 79 (16), 1645-1652, 2012
1202012
The system can't perform the operation now. Try again later.
Articles 1–20